Shionogi & Co., Ltd. (SGIOY) News Today → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free SGIOY Stock Alerts $11.87 -0.06 (-0.50%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Declines By 42.1%marketbeat.com - April 26 at 10:54 AMSGIOY Shionogi & Co., Ltd.seekingalpha.com - March 18 at 11:48 PMShort Interest in Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Grows By 236.1%marketbeat.com - March 12 at 11:53 PMShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Updatemarketbeat.com - March 1 at 6:51 PMShionogi & Co. Ltd. ADRwsj.com - February 15 at 3:39 PMShionogi & Co., Ltd. (4507)uk.investing.com - February 1 at 12:28 PMShionogi & Co., Ltd. (OTCMKTS:SGIOY) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPSmarketbeat.com - February 1 at 9:31 AMHere's what to expect from Shionogi's earningsmarkets.businessinsider.com - February 1 at 7:28 AMShionogi & Co. GAAP EPS of ¥435.74, revenue of ¥336.82Bmsn.com - February 1 at 7:28 AMShionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Down 57.4% in Decembermarketbeat.com - January 13 at 11:52 PMShionogi commences Phase III monovalent Covid-19 vaccine trialmsn.com - December 18 at 3:36 PMShionogi & Co. - ADR (SGIOY) Price Target Increased by 14.91% to 16.05msn.com - December 17 at 10:26 AMApnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for Obstructive Sleep Apnea and other Sleep Disordersbenzinga.com - November 1 at 8:22 PMShionogi & Co., Ltd. (SGIOF)finance.yahoo.com - September 9 at 9:59 AMShionogi USA: IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Diseasefinanznachrichten.de - September 7 at 4:39 PMDaiichi COVID vaccine endorsed in Japan; Shionogi’s shot declinedmsn.com - August 1 at 3:53 PMShionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.finance.yahoo.com - June 26 at 2:53 PMShionogi starts clinical trial for its 2nd oral coronavirus drugmsn.com - May 17 at 1:23 PMECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatmentmarketwatch.com - April 5 at 8:34 AMJefferies Financial Group Comments on Shionogi & Co., Ltd.'s FY2023 Earnings (OTCMKTS:SGIOY)marketbeat.com - March 15 at 2:26 AMShionogi & Co., Ltd. (OTCMKTS:SGIOY) Expected to Post FY2023 Earnings of $1.06 Per Sharemarketbeat.com - March 13 at 2:17 AMShionogi’s Antibiotic, FETCROJA® (cefiderocol), Is Now Available in the Netherlandsyahoo.com - February 22 at 9:31 PMShionogi’s Innovative Antibiotic, FETCROJA® (cefiderocol), Is Now Available in Norwaynz.finance.yahoo.com - January 17 at 9:05 PMShionogi & Co., Ltd. Unsponsored ADR (SGIOY) Upgraded to Buy: Here's Whyfinance.yahoo.com - December 26 at 2:53 PMKaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drugyahoo.com - November 29 at 11:08 AMShionogi seeks Japan approval for COVID-19 vaccinenews.yahoo.com - November 24 at 10:58 AMLeading Japanese Pharmaceutical Company, Shionogi, Officially Opens Doors of Its New European Headquarters in Amsterdamyahoo.com - November 23 at 6:50 AMJapan Approves First Homegrown Covid-19 Antiviral Pillfinance.yahoo.com - November 22 at 7:31 AMJapan's Shionogi shares jump after report of COVID drug gaining efficacy approvalnews.yahoo.com - November 22 at 12:28 AMOrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetesbenzinga.com - November 2 at 9:33 PMShionogi & Co., Ltd. (SGIOY)finance.yahoo.com - September 29 at 10:57 PMShionogi says COVID pill resolves Omicron symptoms faster, meets trial's goalseekingalpha.com - September 28 at 9:57 AMJapan's Shionogi Says COVID Pill Reaches Phase III Milestoneusnews.com - September 28 at 4:56 AMShionogi confirms efficacy of oral COVID drug for Omicron subvariantmsn.com - August 10 at 3:24 AMShionogi & Co. GAAP EPS of ¥115.13, revenue of ¥71.84Bseekingalpha.com - August 3 at 7:19 PMShionogi & Co Ltd ADR (SGIOY)investing.com - August 2 at 11:16 PMShionogi Begins Phase 3 Study in Japan of Akili's Digital Treatment in Children with ADHDbenzinga.com - August 1 at 12:13 PMShionogi Shares Slump After Japan Panel Rejects Emergency Approval for Company's Covid-19 Drugmarketwatch.com - July 20 at 9:30 PMShionogi faces setback for COVID pill as Japan delays authorization againseekingalpha.com - July 20 at 11:27 AMShionogi Announces Strategic Re-Organization of U.S. Executive Leadershipapnews.com - June 1 at 5:46 PMShionogi says oral COVID-19 therapy rapidly cleared virus in mid-stage trialseekingalpha.com - April 25 at 8:30 AMJapan's Shionogi says COVID-19 pill shows rapid clearance of virusnews.yahoo.com - April 24 at 12:06 PMPfizer set to add nearly $24 billion revenue with COVID-19 pill - Airfinityseekingalpha.com - April 22 at 6:37 PMUPDATE 2-Shionogi shares plunge on concerns over COVID pill risk to pregnanciesreuters.com - April 13 at 9:48 AMShionogi shares plunge 15% on report of COVID pill birth defect risknasdaq.com - April 13 at 1:58 AMShionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticalsmarkets.businessinsider.com - April 6 at 12:44 PMShionogi gets FDA nod to begin phase 3 study of oral COVID drug S-217622seekingalpha.com - March 16 at 11:53 AMShionogi Says Covid-19 Vaccine Found Effective and Safe in Studybloomberg.com - March 4 at 5:50 AMShionogi files for approval of COVID-19 oral drug in Japanseekingalpha.com - February 25 at 9:03 AMJapan's Shionogi seeks approval for COVID-19 pillnews.yahoo.com - February 25 at 1:28 AM Get Shionogi & Co., Ltd. News Delivered to You Automatically Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide SGIOY Media Mentions By Week SGIOY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGIOY News Sentiment▼0.000.38▲Average Medical News Sentiment SGIOY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGIOY Articles This Week▼00▲SGIOY Articles Average Week Get Shionogi & Co., Ltd. News Delivered to You Automatically Sign up to receive the latest news and ratings for SGIOY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SDZNY News ERFSF News SSMXY News SKHHY News AMFPF News SBMFF News APNHY News ORINY News HKMPF News ZLDPF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SGIOY) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shionogi & Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
